BI3S209 - Modern Molecular Advances 01 Jul 2022 - 31 Aug 2028 | Version 1
Associated Module Information
| Module Code: | BI3S209 | ||
|---|---|---|---|
| Module Title: | Modern Molecular Advances | ||
| Faculty: | Faculty of Computing, Engineering and Science | ||
| Faculty Group: | Biological and Forensic Sciences | ||
| Faculty Sub Group: | Biological Science | ||
| Module Leader: | Sioned Owen | ||
| Module Team: | Martin Powell, Aled Bryant, Aaron Wall, Cerith Jones, Josephine Bradley | ||
| First Intended Intake: | SEP 2022 | Final Year of Intake: | 2027 |
| Date Closed: | |||
| Credit Value: | 20 | Credit Level: | 6 |
| Language: | English | ||
| Percentage of Module Taught in Welsh: | 0 | ||
| Equivalent Module: | |||
| HECOS codes: | 100354 - molecular biology | ||
| HECOS Code Weighting: | 100 | ||
Document Version Information
| Version | 1 |
|---|---|
| Valid From | 01 Jul 2022 |
| Valid To | 31 Aug 2028 |
Module Aims
On successful completion of this module students will be able to critically evaluate the therapeutic and technological advances which have successfully made it into clinical practice for diagnosis and disease management.
The module is delivered through a combination of lectures, tutorials and case studies.
In engaging with the module, students will fully achieve the following level appropriate behaviour domains of the USW graduate attributes:-
Communication: Behaviours 1 and 2
Innovation and enterprise: Behaviours 1, 2, 3
Digital literacy: Behaviours 1, 2
Commercial awareness: Behaviours 1, 2
The capabilities associated with these behaviours are found in the graduate attributes listed at the end of the descriptor.
Content Summary
Topics covered in biomedical advances will include, but are not limited to:-
Gene therapy
Personalised medicine, diagnostic screening, monitoring and management of disease.
Prophylactic and therapeutic vaccine strategies
Immunogenetics and disease
Immuno-oncology agents and their role in cancer therapy
Neuropharmacology
Learning and Teaching Methods
| Activity Type | Hours |
|---|---|
| Independent Study | 160 |
| Tutorial | 40 |
| Total Hours Selected | 200 |
Learning Outcomes
| # | Learning Outcome |
|---|---|
| LO1 | Critically appreciate how impaired biochemical and genetic pathways can lead to disease and how medical advances have contributed to their diagnosis, management and treatment |
| LO2 | Critically evaluate the role of clinical biochemistry and molecular biology techniques in diagnosis and disease management |
Module Requisites
| Code | Title | Requisite Type |
|---|---|---|
| MOD012910 | Human Molecular Genetics | pre-requisite |
Assessment Criteria
| Assessment Category | Assessment Type | Description | Duration | Word Count | Weight (%) | Best of? | Pass Mark |
|---|---|---|---|---|---|---|---|
| Synchronous Onsite Assessment (Exam) | Onsite Closed Book Examination 1 | Written Examination – closed book | 120 | N/A | 50 | No | 40 |
| Synchronous Onsite Oral Assessment | Oral Assessment (Internally assessed, Onsite) 1 | Experimental research plan for a genetic/biochemical novel research idea | 15 | N/A | 50 | No | 40 |
Assessment Matrix
| Assessment Type | Learning Outcomes | ||
|---|---|---|---|
| LO1 | LO2 | ||
| Onsite Closed Book Examination 1 | ✔ | ✔ | |
| Oral Assessment (Internally assessed, Onsite) 1 | ✔ | ✔ | |